Robohub.org
 

ETH and University of Zurich launch Wyss Translational Center Zurich

by
12 December 2014



share this:
ETH_Zurich

ETH and the university of Zürich receive a 120 million dollar donation from ETH alumnus Hansjörg Wyss. (All photos: ETH Zurich)

ETH Zurich and the University of Zurich are founding a new translational research centre at the interface of medicine, science and engineering: the Wyss Translational Center Zurich. A USD 120 million donation from Dr. h.c. mult. Hansjörg Wyss to the two Zurich universities is making this possible. Through an interdisciplinary approach, the new centre aims to accelerate the development and application of innovative medical therapies and groundbreaking robotic systems.

ETH Zurich and the University of Zurich (UZH) are taking their long-standing partnership to a new level with a new translational research centre. The two universities are founding the Wyss Translational Center Zurich (WTZ) with funds donated by Hansjörg Wyss to the ETH Zurich Foundation. The core idea and motivation behind the initiative is to ensure that knowledge from basic and pre-clinical research can be applied in practice more quickly; in other words, an efficient translation into new medical therapies and innovative products.

The WTZ will initially include two technology platforms – one for regenerative medicine and the other for robotics. The centre will bridge disciplinary and institutional barriers and unite researchers across various disciplines, ranging from technology and medicine through to materials science, stem cell research and robotics. “Basic research in Switzerland is among the best in the world. However, it often takes a long time until the findings can be used to benefit patients. I want to help speed up this transfer with new models of interdisciplinary collaboration”, states Wyss, founder of the medical technology company Synthes Global and chairman of the Wyss Foundation.

The USD 120 million donation is a basic endowment to establish and operate the WTZ for the first seven years. ETH Zurich and UZH will provide personnel and infrastructure in the new centre. On the basis of the two translational technology platforms – regenerative medicine and robotics – the WTZ will commence operations in 2015 with a starting portfolio of four translational projects: Zurich Life Matrix, Zurich Heart/Ventricular Assist Devices, Zurich Liver and Zurich Eye. More groundbreaking transfer projects will be added over time. “The generous donation from ETH alumni Hansjörg Wyss provides a fantastic opportunity to use the many different scientific competences and skills here in Zurich to develop new medical and robotics products,” says ETH President Ralph Eichler. The new research centre will be based at both ETH and the University of Zurich and will be co-directed by professors Roland Siegwart (ETH Zurich) and Simon P. Hoerstrup (UZH). “Combined with the excellent basic research at the University of Zurich and ETH’s proven strength in technology development, the Wyss Translational Center will allow our two institutions to assume a very strong position among the international competition,” states Michael O. Hengartner, rector of the University of Zurich.

From research to product

ETH Alumnus Hansjörg Wyss with the two WTZ Co-Directors , Prof. Roland Siegwart (right) and Prof. Simon P. Hoerstrup.

ETH Alumnus Hansjörg Wyss with the two WTZ Co-Directors , Prof. Roland Siegwart (right) and Prof. Simon P. Hoerstrup.

Within the four starting research projects, the two partner institutions are aiming to develop new medical treatments, prototypes and innovative products over the coming years in order to improve the lives of patients and healthy people. An overview of the objectives of the four research projects:

Zurich Life Matrix: Development of in-vitro engineered human tissues that can regenerate and grow along with the organism. For example, scientists are growing blood vessels and heart valves in laboratories from human cells that can evolve in parallel with the heart (e.g. during the growth stages of a child) and have the capacity for self-repair. Existing solutions are usually of a non-living, prosthetic nature and, as a result, lead to complications that require surgical re-interventions often associated with substantial morbidity and mortality.

Zurich Heart/Ventricular Assist Devices: Development of innovative heart support pumps (ventricular assist devices). Many people today suffer from life-threatening heart problems. Artificial heart pumps support the diseased failing heart allowing patients to enjoy a good quality of life in the long term despite the lack of suitable donor hearts. However, there is still much room for improvement related to the biocompatibility, control, ergonomics and size of existing heart support pumps.

Zurich Liver: Development of innovative extra-corporeal perfusion systems. This will allow, for instance, a part of a patient’s liver to be grown outside the body and be transplanted back into the patient. This process would enable patients with serious liver diseases such as cancer to generate their own donor material and significantly decrease the demand for donor organs while increasing patient safety at the same time. The process could then be applied to allogenic transplantations and pave the way for one donor liver benefiting more than one patient.

Zurich Eye: Development of a camera-based positioning system that automatically creates maps of the environment and enables precise positioning. This system is intended to help autonomous vehicles and aircrafts navigate independently in disaster operations, transport and agriculture, and support people in various tasks.

This article originally appeared on ETH News.



tags: , , , , , ,


ETH Zurich is one of the leading international universities for technology and the natural sciences.
ETH Zurich is one of the leading international universities for technology and the natural sciences.





Related posts :



ep.

339

podcast

High Capacity Ride Sharing, with Alex Wallar

Robohub Podcast · Public Transit https://www.youtube.com/watch?v=vgstBxWFFZQ [space] In this episode, our interviewer Lilly speaks to Alex Wallar, co-founder and CTO of The Routing Company. ...
12 October 2021, by

50 women in robotics you need to know about 2021

It’s Ada Lovelace Day and once again we’re delighted to introduce you to “50 women in robotics you need to know about”! From the Afghanistan Girls Robotics Team to K.G.Engelhardt who in 1989 ...
12 October 2021, by and

Join the Women in Robotics Photo Challenge

How can women feel as if they belong in robotics if we can't see any pictures of women building or programming robots? The Civil Rights Activist Marian Wright Edelson aptly said, "You can't be what yo...
12 October 2021, by

Sense Think Act Podcast: Melonee Wise

In this episode, Audrow Nash speaks with Melonee Wise, former CEO of Fetch Robotics and current VP of Robotics Automation at Zebra Technologies. Melonee speaks about the origin of Fetch Robotics, her ...
11 October 2021, by and

Online events to look out for on Ada Lovelace Day 2021

On the 12th of October, the world will celebrate Ada Lovelace Day to honor the achievements of women in science, technology, engineering and maths (STEM). After a successful worldwide online celebrati...
10 October 2021, by

Flying high-speed drones into the unknown with AI

When it comes to exploring complex and unknown environments such as forests, buildings or caves, drones are hard to beat. They are fast, agile and small, and they can carry sensors and payloads virtua...
08 October 2021, by





©2021 - ROBOTS Association


 












©2021 - ROBOTS Association